Objective: To examine the population-wide overdose risk emerging from the prescription of methadone and buprenorphine for opioid substitution treatment in England and Wales. Design: Retrospective administrative data study. Setting: National databases for England and Wales. Participants/cases: Drug-related mortality data were drawn from the Office for National Statistics, and prescription data for methadone and buprenorphine were obtained from the National Health Service for the years 2007–2012. During this 6-year period, a total of 2366 methadone-related deaths and 52 buprenorphine-related deaths were registered, corresponding to 17 333 163 methadone and 2 602 374 buprenorphine prescriptions issued. The analysis encompassed poisoning deaths...
OBJECTIVE: To evaluate the impact of introduction of supervision of methadone dosing on deaths relat...
AimsTo estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is assoc...
Due to publisher restrictions the full text of this article is not available in the UHRABuprenorphin...
Objective: To examine the population-wide overdose risk emerging from the prescription of methadone ...
AIMS: To estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is ass...
Study objective-Although the total number of self poisonings in England and Wales has dropped by 32%...
Study objective-Although the total number of self poisonings in England and Wales has dropped by 32%...
Background: Opiate substitution treatment (OST) is the main treatment for people addicted to heroin ...
Background The UK heroin market is the biggest in Europe and ~70 % of heroin deaths are due to fatal...
AIMS: To compare the change in illicit opioid users' risk of fatal drug-related poisoning (DRP) asso...
Aims: To examine the risk of mortality associated with interruptions to the continuity of methadone ...
BACKGROUND: The first evidence that the hazard ratio (HR) for methadone-specific death rises more st...
Aim: To quantify gender, age-group and quantity of methadone prescribed as risk factors for drugs-re...
BACKGROUND: Overdose is a major cause of death among PWID, and for opioid overdoses naloxone adminis...
AIM: To quantify gender, age-group and quantity of methadone prescribed as risk factors for drugs-re...
OBJECTIVE: To evaluate the impact of introduction of supervision of methadone dosing on deaths relat...
AimsTo estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is assoc...
Due to publisher restrictions the full text of this article is not available in the UHRABuprenorphin...
Objective: To examine the population-wide overdose risk emerging from the prescription of methadone ...
AIMS: To estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is ass...
Study objective-Although the total number of self poisonings in England and Wales has dropped by 32%...
Study objective-Although the total number of self poisonings in England and Wales has dropped by 32%...
Background: Opiate substitution treatment (OST) is the main treatment for people addicted to heroin ...
Background The UK heroin market is the biggest in Europe and ~70 % of heroin deaths are due to fatal...
AIMS: To compare the change in illicit opioid users' risk of fatal drug-related poisoning (DRP) asso...
Aims: To examine the risk of mortality associated with interruptions to the continuity of methadone ...
BACKGROUND: The first evidence that the hazard ratio (HR) for methadone-specific death rises more st...
Aim: To quantify gender, age-group and quantity of methadone prescribed as risk factors for drugs-re...
BACKGROUND: Overdose is a major cause of death among PWID, and for opioid overdoses naloxone adminis...
AIM: To quantify gender, age-group and quantity of methadone prescribed as risk factors for drugs-re...
OBJECTIVE: To evaluate the impact of introduction of supervision of methadone dosing on deaths relat...
AimsTo estimate whether opioid substitution treatment (OST) with buprenorphine or methadone is assoc...
Due to publisher restrictions the full text of this article is not available in the UHRABuprenorphin...